News Daily News European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs Shelley Wood December 18, 2018
News Conference News WCC 2018 E-Cigarettes: Plausible Heart Risks Flagged in New Review Todd Neale December 10, 2018
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Daily News FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients Yael L. Maxwell December 05, 2018
News Daily News Quality of Anticoagulation Therapy Lower in Black Patients With A-fib Todd Neale December 03, 2018
News Daily News Global Investigative Journalism Initiative Takes Aim at Medical Device Industry Todd Neale November 26, 2018
News Daily News Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data Michael O'Riordan November 26, 2018
News Daily News PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study Michael O'Riordan November 23, 2018
News Daily News Treating to New Blood Pressure Goals Could Prevent Millions of CVD Events L.A. McKeown November 21, 2018
News Daily News FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R Todd Neale November 20, 2018
News Daily News Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab Yael L. Maxwell November 14, 2018
News Conference News AHA 2018 PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure Michael O'Riordan November 11, 2018
News Conference News AHA 2018 Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI Todd Neale November 11, 2018
Presentation AHA 2018 Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial Presenter: Sotirios Tsimikas November 11, 2018
News Conference News AHA 2018 Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study Shelley Wood November 11, 2018
News Conference News AHA 2018 Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab Yael L. Maxwell November 10, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018